首页> 外文期刊>American journal of cardiovascular drugs: drugs, devices, and other interventions >Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?

【24h】

Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?

机译：增加比伐卢定在经皮冠状动脉介入治疗中的益处：出血的高风险是关键吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《American journal of cardiovascular drugs: drugs, devices, and other interventions》 |2015年第4期|共4页
作者
Angeli Fabio; Reboldi Gianpaolo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
入库时间 2022-08-18 09:59:34

相似文献

外文文献
中文文献
专利

1. Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key? [J] . Angeli Fabio, Reboldi Gianpaolo American journal of cardiovascular drugs: drugs, devices, and other interventions . 2015,第4期

机译：增加比伐卢定在经皮冠状动脉介入治疗中的益处：出血的高风险是关键吗？
2. Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies [J] . Pasala Tilak, Gajulapalli Rama Dilip, Bolen Shari, International Journal of Cardiology . 2016,第Null期

机译：经radi动脉通路减轻了比伐卢定比肝素对经皮冠状动脉介入治疗患者的出血益处：随机和观察性研究的荟萃分析的见解
3. Exploration of Bivalirudin Use during Percutaneous Coronary Intervention for High Bleeding Risk Patients with Chronic Total Occlusion [J] . Chenguang Li, Yi Shen, Rende Xu, International heart journal . 2018,第2期

机译：高血脂风险慢性完全闭塞患者经皮冠状动脉介入治疗中比伐卢定使用的探索
4. Guidance of Percutaneous Coronary Interventions with NIRS-IVUS for Improvement of Procedural Outcomes and Prediction of Future Risk of Coronary Events [C] . Stephanie Grainger, Cherry Greiner, Priti Shah, Multimodal Biomedical Imaging XIV . 2019

机译：用NIRS-IVUS进行经皮冠状动脉介入治疗以改善手术结局和预测冠状动脉事件未来风险的指南
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients at High Risk for Bleeding [O] . Alexander Feldman, Khalid Suleiman, Limor Bushari, 2014

机译：高出血风险患者经皮冠状动脉介入治疗期间比伐卢定与普通肝素
7. Exploration of Bivalirudin Use during Percutaneous Coronary Intervention for High Bleeding Risk Patients with Chronic Total Occlusion [O] . Chenguang Li, Yi Shen, Rende Xu, 2018

机译：高渗患者经皮冠状动脉介入治疗慢性总闭塞性患者的双冠状动脉介入探索

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号